Status:
COMPLETED
Rheumatoid Arthritis Disease Activity Monitor
Lead Sponsor:
Maxima Medical Center
Collaborating Sponsors:
Philips Research Europe
Conditions:
Rheumatoid Arthritis
Eligibility:
All Genders
18+ years
Brief Summary
Background of the study: Rheumatoid Arthritis (RA) is an autoimmune disease. There are four stages of the disease: 1. Synovial inflammation 2. Swelling of synovium 3. Pannus formation 4. Advanced bo...
Eligibility Criteria
Inclusion
- Diagnosed with Rheumatoid Arthritis
- Inflamed PIP joint of at least one index finger (moderate or severe)
- Disease activity of specific joints known (swelling, tenderness)
- No significant deformations of the hand or fingers
- More than 18 years old
Exclusion
- Recent surgery or operation, in the last three months, on the arm or fingers that will be tested with the RADAM RRC
- Inability to give informed consent
Key Trial Info
Start Date :
January 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2009
Estimated Enrollment :
75 Patients enrolled
Trial Details
Trial ID
NCT00989677
Start Date
January 1 2009
End Date
June 1 2009
Last Update
October 5 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Maxima Medical Centre
Eindhoven, Netherlands, 5600PD